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ABSTRACT
An analysis of several G418-resistant ES cell lines
produced by electroporation of a promoterless neoR
gene (NASTI), shows an enrichment for integrations
within, or adjacent to, CpG islands. A detailed analysis
of two of the cell lines reveals short regions of
homology between the genomic target DNA and the
construct ends, and that recombination may be
mediated by DNA Topoisomerase 1. The DNA flanking
the insert detects transcription of endogenous genes,
and in one cell line divergent transcripts are detected.
This use of ES cells should provide an effective and
efficient means of creating insertional mutations in
mice.
INTRODUCTION
Embryonic stem (ES) cells are pluripotent stem cells derived from
the mouse blastocyst inner cell mass. Cell lines can be maintained
in an undifferentiated state in culture (1,2), where they can be
genetically manipulated and characterized. The ES cells can then
go on to form chimaeras by microinjection into host mouse
blastocysts. The mosaic of host and ES cells produces a chimaeric
animal in which the ES cells are able to contribute to all cell
types (3). Most importantly the manipulated ES cells are able
to contribute to the germ line through which the phenotype of
a mutation, which had been previously characterized in vitro,
can be assessed in succeeding generations in both heterozygous
and homozygous form. The use of ES cells has received much
attention recently as a means of gene targetting by homologous
recombination (4).
We are interested in identifying, cloning and mutagenizing
genes involved in the early stages of development and
morphogenesis in the mouse, and genes which are active in ES
cells will include some of these. We have therefore developed
a method by which random genes active in ES cells can be
identified and mutated by means of a promoter-trap. The construct
used for transfection is essentially a promoterless neoR gene.
Only cells in which the insertion has occurred in the correct
orientation next to an active promoter will be able to express
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the neoR gene and will therefore survive G418 selection. The
cloning of the DNA flanking the insertion sites allows a detailed
analysis of the integration sites of these non-homologous or
'illegitimate' recombination events.
Several cell lines have been produced from G418 resistant foci,
resulting from a single transfection experiment, and in each of
these the transfected DNA has integrated into different regions
of the mouse genome. Analysis of cell line DNA reveals that
in six of seven lines examined the integrated DNA has inserted
close to or within a CpG island. Such islands are found at the
5' end of all housekeeping genes and some tissue specific genes
(5,6) and are associated with a different chromatin structure (7).
The precise genomic integration sites in two of the cell lines
have been analysed in detail, and there are homologies to
consensus recognition sites for DNA topoisomerase I at the
breakpoints. There are also short regions of homology between
the target DNA and the construct ends. We discuss the possibility
that DNA topoisomerase I may be involved in mediating the
recombination events in these cell lines.
EXPERIMENTAL METHODS
Cell culture and electroporation
In the original transfection experiment from which the cell lines
were derived, CCE ES cells (8), were electroporated with the
linearized DNA construct NASTI, at 0.01 mg/ml, using a
wokshop-made apparatus (9). ES cells were cultured using BRL
conditioned media and mitomycin-treated, STO feeder cells, in
DMEM, 20% foetal calf serum, 0.1 mM 2-mercaptoethanol (10).
The cells were selected with G418 at 0.3 mg/ml for at least 10
days before foci were picked. In the transfection experiment to
test promoter activity, E14, ES cells were used (gift from
M.Hooper, Dept. Pathology ). Which were grown in modified
Eagles medium (Flow Labs), supplemented with IX nonessential
amino acids, 1mM sodium pyruvate, 10% foetal calf serum, 0.1
mM 2- mercaptoethanol and 103 units/mil LIF (ESGRO,
Amstrad Corporation, Victoria, Australia). Electroporation was
as described (11). G418 selection was imposed after 48 hrs, at
0.2 mg/ml, and was complete after 10 days.
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Recombinant libraries and DNA cloning
DNA was prepared from cell lines 19/7 and 19/8 (12), and 0.05
mg of DNA was fractionated on a 1% low melting point agarose
gel. DNA of the correct size fraction containing the neoR insert
was isolated using agarase digestion (13). Genomic libraries wer
made from this DNA in lambda L47 phage (14). Ihe phage DNA
was digested with Bam HI, ligated with the fractionated genomic
DNA and packaged using Gigapack-Gold (Stratagene).
Recombinant phage were selected on Mcr-(P2), NM646 cells
(N.Murray, Dept.Mol.Biol. Edinburgh University), and the
library was amplified before replating on NM430 cells which
have an amber mutation in the LacZ gene (N.Murray).
Recombinant phage which contained the SupF gene from the
NASTI construct (see Fig. 1), were identified by their blue colour
on X-Gal plates by complementation of the LacZ amber mution.
DNA was prepared from isolated recombinants (15). As the
bluescribe vector is contained within NASTI, subclones
containing mouse flanking DNA were quickly obtained by
digesting the phage DNA with Hind mI or Eco RI, self-ligating
the products and using this to transform competent JM83 cells
(16). Other subclones were made from DNA isolated from low
melting point gels, and cloned into bluescribe vector (SStagene).
The cDNA clone p8E2 was isolated from an 8.5 day mouse
embryo cDNA library in lambda gtlO (B.Hogan, MRC NIMR
Mill Hill and K.Fahrner, Biogen), using probe 8A. The cDNA
was cloned into bluescribe vector, in both orientations, and
subclones made using a variety of enzymes to enable the cDNA
to be sequenced on both strands.
Nucleic acid hybridizations
RNA samples (0.01 mg/track), were fractionated on agarose-
formaldehyde gels (15), and blotted onto Hybond-N nylon
membranes (Amersham UK). DNA (0.01 mg/track), was
fractionated on agarose gels and blotted (17) to Hybond-N. The
nucleic acids were fixed to the nylon membrane in acordance
with the manufacturers instructions and hybridized to labelled,
random primed DNA isolated from agarose gels (18).
Hybridizations were carried out in a buffer containing 0.5M Na
Phosphate, (pH7.2); 7% SDS; 1mM EDTA at 68°C (19) and
filters were given several washes of 30 mins. each in 2-0.5 x
SSC/0. 1% SDS, at 68°C. They were then exposed to Kodak
XAR-5, X-ray film, for various exposure times.
PCR analysis
DNA oligomers were made with an Applied Biosystems 381A
DNA synthesizer, and were designed so that they contained a
restriction enzyme site which could be used to clone the PCR
product. Primer sequences from the cloned 5' and 3' flanking
DNA were; 5'-AGAGGCATGCGGTCGTCCTCCTTC-3' and
5'-CTTACACAGGCCTGTGGGTA-3' from 19/7 and; 5'-GC-
TGGGCAAGCTTGCTGCCC-3' and 5'-GCTCCTGCAGAAA-
CAGGAAAGG-3' from 19/8. The amplification of the genomic
DNA by PCR was as described (20). The PCR reactions were
performed using 0.001 mg CCE DNA, with 50 pM of each
primer, in 0.05 ml reaction mix containing 50 mM KCI/1.5 mM
MgCl/10 mM Tris pH 8.25/0.2 mM dNTPs and 5 units Taq
polymerase (Amersham UK). A Techne PHC-2 PCR machine
was used for 30 cycles set at; 920C for 1.5 min, 550C for 1.5
min, 720C for 2 min. The PCR products were then digested with
Sph I/Stu I (19/7), or Hind m/Pst I (19/8), and cloned into
bluescribe for sequencing.
Enzymes and sequencing
All nuceic acid restriction enzymes and mdixfyng enzymes werefrom Boehringer-Mannheim Biochemicals or New England
Biolabs. Sequencing was by the chain terminator method (21),
using double stranded plasmids and a Sequenas kdt (USB). Ihe
primers used for sequencing were the universal or M13 primers
(NEB), or a synthesised DNA oligomer from the 5' end neoP
gene.
RESULTS
ES cell transfection
ES cells were transfected by electroporation with a promoterless
neoR gene construct NASTI (Neo Activated Selection for
Targeted Integration), Figure. la.(see Materials and Methods).
This construct was originally designed to mutate the mouse Hox
2.1 gene by homologous recombination. G418-resistant foci were
picked and cultured to produce nine different cell lines.
Southern blots of gel fractionated Bgl II and BamHi resd
DNA from each cell line, probed with the neoR gene, showed
that the vector had inserted into single sites in seven of nine
selected lines (data not shown). The single hybridizing bands were
also of different sizes which suggests that the insertions had
ocurred at different loci. These cell lines were sbected to furth
analysis; in these lines the neoR gene must have trapped an
active ES cell promoter.
Most insertions are in close proximity to CpG islads
Promoters for many genes lie within CpG islanis. It was tierefore
of interest to determine whether the integration events were
adjacent to such islands. CpG islands are relatively G+C rich
regions, usually 1-2 kb in length, which are not deficient in
the dinucleotide CpG, unlike the rest of the genome (22). CpG
islands are found at the 5' end of all known housekeeping genes,
as well as some tissue specific genes, and contain transcriptional
start sites (5,6). The use of rare-cutting restriction enzymes that
contain CpGs in their recognition sequence is a convenient
method of detecting such regions. In particular clustered sites
for Not I, Sma I, Nae I, Nar I, Sac II, Bss HII, or Eag I, are
diagnostic of a CpG island. Sites for these enzymes occur only
rarely elsewhere in the genome and when they do are mostly
blocked by methylation (23,24).
These rare cutter sites were mapped in each of the cell lines
using southern blots of gel fractionated DNA, hybridized to DNA
probes from within the insertion construct (Figure lb.). In this
experiment only restriction enzyme sites proximal to the insert
are mapped; there may of course be multiple sites for some of
these enzymes. In all cell lines except 19/10, there was a cluster
of rare cutter sites flanking or adjacent to the inserted DNA. This
indicates that in six of the seven lines examined the insertions
have occured within or adjacent to a CpG island. In most cases
the clusters of sites are within the 5' flanking DNA or on both
sides. In line 19/2 a second NASTI insert has integrated in
tandem. There are island-cutter sites in the 5' flanking DNA.
The close proximity of CpG islands suggests that the promoters
contained within these regions are controlling neoR tnwription.
The insertion of the neoR gene would produce a hybrid RNA
from which an effective neoR protein must be translated.
The size of the neoR transcripts further indicate that
insertions have occured close to the 5' end of genes
A Northern blot of total RNA from each cell line, and
untransfected control ES cells, was probed with the neoR gene.
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Figure 1. (a) The promoterless neoR gene construct, NASTI, used in the transfection experiment. The neoR gene has had a 5' in-frame stop codon removed and
has the HSV-Tk poly-A signal at its 3' end (9). The construct also contains the bluescribe vector, the bacterial SupF gene isolated from the PiVX plasmid (50),
and a 200 bp Eco RI/Bam HI fragment from the 5' end of Hox 2.1 cDNA (51). The vector was linearized before transfection by using a unique Sac I site in the
centre of the Hox 2.1 sequence, which places Hox 2.1 sequence at both ends of the construct. (b) A restriction map representing the inserted NASTI construct
(hatched area), and flanking mouse DNA (solid line), in each of the cell lines. The vertical bars represent restriction sites for the following enzymes, Bs=Bss HII;
E=Eag I; Na=Nae I; No=Not I; Nr=Nar I; Sc=Sac II; Sm=Sma I. The data was accumulated from southern blots of genomic DNA from each cell line restricted
with the above enzymes, hybridised with probes from within the construct.
Each of the cell lines show hybridization to the neoR probe
(Figure.2). The intensity of the signal varies between each track.
Some variation is due to unequal loading, but when compared
to the actin control there is clearly a variation in activity of the
endogenous promoters. The transcript sizes also vary to some
extent, between approximately 1.5 and 1.8 kb. The size of the
neoR gene is 1.1 kb. The transcriptional start sites are in flanking
DNA, within only a few hundred base pairs of the 5' end of the
insert. Preliminary analysis by primer extensions reveals that the
transcriptional start sites in several cell lines are within 200 bp
upstream of the neoR gene and that in some cases multiple start
sites lie within the Hox 2.1 sequence of NASTI (data not shown).
The close proximity of the transcriptional start sites suggests there
is selection for integrations close to the 5' end of genes possibly
because longer hybrid transcripts are less likely to produce a
functional neoR protein. However, long hybrid mRNAs are
known in some cases to be functional (25,26) and it may be that
the chromatin at the 5' ends of genes is more susceptible to DNA
integration.
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Figure 2. A Northern blot of total RNA (0.01 mg per track), from each of the
transfected cell lines and of a non-transfected line, CCE and probed with the
neoR gene (upper panel), or an actin control probe (lower panel). Hybridization
to the neoR gene in each of the transfected cell lines is marked-n. The band
marked-b indicates a cross-hybridizing band which is present in all of the tracks
including the control non transfected line CCE.
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Cloned flanking DNA from cell lines 19/7 and 19/8 confirms
their CpG island nature
To enable a more detailed study to be made of the integration
sites and flanking DNA, clones from cell lines 19/7 and 19/8
were selected. Both contain flanking mouse DNA 5' and 3' of
the insert. Restriction enzyme sites witiin the flanking DNA were
mapped. Sites for the CpG island locating enzymes confirmed
the data from genomic blots and we detcted additional multiple
sites for some of these enzymes (Figure.3). The genomic DNA
sequences at the insertion sites in 19/7 and 19/8 (see Figure.5),
are over 50% G+C, with CpG roughly equal to GpC, meeting
the criteria for a CpG island (22). These sequence analyses
therefore confirm that DNA 5' of the insert in both 19/7 and
19/8 is a CpG island.
Analysis of the integration points in 19/7 and 19i8 reveals
short regions of homology between the genokDNA and the
construct ends
Probes from flanking 5' DNA in 19/7 and 19/8 were used to
determine if there had been any gross rearrangement of the host
DNA at the integration sites. Probes 7A and 8A (see Figure.3),
were used to probe southern blots of DNA from the 19/7 and
19/8 cell lines and of a non-transfected line, CCE. There is no
detectable rearrangement or deletion of the genomic sequence
at the integration sites. The presence of an additional Bgl fl band
in each of the cell line DNAs was consistent with there being
a clean insertion of the construct into one chromosoml site,which
increases the normal Bgl II band size by the approximate size
of the integrated DNA (data not shown). To analyse the
integration sites in detail, the juncion sites were sequenced. These
were compared to the sequences of the normal genomic DNA,
determined by PCR (20), using DNA primers, 5' and 3' of the
insertions.
Genomic sequences surrounding the insertion sites are
presented in Figs.4a and 4b. A comparison between the normal
genomic sequences and the DNA sequences of the integration
junctions in 19/7 and 19/8, revealed no loss of DNA from the
host. The points of integration are marked with an asterisk, and
in both cell lines the sequence 5'-AACTC-3' appears immediately
5' of this. This sequence is complementary to 3/4 bases at the
5' end of the insertion vector 3'-TCGAG-5'. There is also a short
region of homology between the vector 3' end and the genomic
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DNA 3'< of the integration, 4 bp in 19/7, 5'-CAAA-3', and a
possible single T in 19/8 (Fig.4c). It is not possible to determine
which of the bases at the junction points belong to the vector
and which are of host origin. This suggests that the insertion has
occurred by recombination in the region of sequence similarity.
The subcloned 5'flanking DNA contains promoter elements
To determine if the DNA immediately 5' of the neoR gene in
19/7 and 19/8 contained promoters, the linearized subclones
contning the neoR gene, and approximately 1 kb of flanking
mouse DNA, were used to transfect ES cells. If the mouse DNA
contains a promoter which directs neoR expression, the
frequency of transfectants should be much higher than in a
promoterless control, after G418 selection. The data (Table I),
show a 100-fold higher transfection frequency for the 19/7 and
19/8 over the promoterless NASTI vector, comparable to the
promoter-containing controls pSv2neo (27) and pMCneoPolyA
(28). The data therefore confirm that in cell lines 19/7 and 19/8
the promoters controlling neoR expression are contained in the
genomic DNA within lkb of the integration site.
The coned flanking DNAs from 19/7 and 19/8 detect
transcipts from endogenous genes
As NASTI has integrated downstream of a promoter,
transcription of the endogenous genes may be detected using the
mouse DNA flanking the insert. We therefore used DNA probes
7A and 8A (see Figure.3), to determine if endogenous gene
transcription from the trapped promoters in 19/7 and 19/8 was
Table I. Results of a transfection experiment using linearized DNA vectors
tansfected into ES cells
DNA Number of cells Mean number Frequency
electroporated of colonies
NASTI 107 415 4.1 x 10-5
pSV2neo 2.5 x 104 121 4.8 x 10-3
pMCneoPolyA 2.5 x 104 168 6.7x 10-3
p7R1 2.5 x 104 175 7.0x 10-3
p8H2 2.5x 104 148.5 5.9x 103
The p7Rl clone contains genomic DNA 5' of the insertion in cell line 19/7, and
the p8H2 clone contains genomic DNA flankdng the insertion in 19/8.
neoRBs
19/7
neoR
19/8
500bp
Figure 3. A map showing sites for rare-cutting restriction en IIs in the cloned mouse DNA 5' of the insert in cell lines 19/7 and 19/8. The DNA probes 7A
and 8A are indicated. These probes are from subclones p7Rl and p8H2 using Ava I digestion. They contain 25 bp of Hox 2.1 DNA from the vector end. The
genomic Hox 2.1 sequence is not detected on blots due to the high stringency used. Enzymes are abrieviated as in Fig. 1 and in addition, Ml=Mlu I.
Nucleic Acids Research, Vol. 19, No. 1 21
detectable. The probes were hybridized to Northern blots
produced from total RNA from a variety of tissues.
Probe 7A, detects feint bands in most tissue types but shows
strong hybridization to testis RNAs of approximately 2.0 and 3.1
kb (Figure.5a). The same bands are also detected with a 3' probe
(data not shown). Probe 8A also shows strong hybridization to
testis RNA and produces strong bands of approximately 3.2 kb,
2.2 kb and a heterogeneous band of 1.2 to 1.3 kb. There is also
hybridization to different RNAs in other tissues; an approximately
2.5 kb band in brain and a 2.8 kb band in muscle (Figure.5b).
A cDNA clone, p8E2 isolated from an 8.5 day mouse embryo
library screened with 8A, hybridizes to the small 1.2-1.3 kb
transcript (Fig.5c). We suggest, therefore, that several transcripts
derive from the 8A region, one of which is testis specific.
Expression has also been detected in ES cells using probe 8A
on a Northern blot of polyA+ RNA, and hybridizes to a band
of approximately 1.8 kb (not shown). We detected very weak
hybridization with 7A with poly A+ RNA from ES cells. It is
a
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Figure 4. (a) The genomic DNA sequence flanking the insertion site in 19/7. The asterisk represents the point of insertion and the direction of neoR transcription
is indicated. (b) The genomic DNA sequence flanking the insertion site in 19/8. The asterisk represents the point of insertion and the direction of neoR transcription
is indicated. The underlined sequence is the same as the 5' end of the p8E2 cDNA clone and continues upto a consensus splice site (29), on the opposite strand.
A TATA-like box is double underlined, as is the consensus CAAT box (52). GC boxes are enclosed in brackets. (c) Sequence homologies present at the integration
sites in 19/7 and 19/8. Homologous bases between the normal genomic DNA, the transfected cell line DNA and the insertion construct are shown as vertical lines.
The asterisk in 19/8 denotes a base which could be on either side of the genomic breakpoint. The 5 bp sequence, AACTC, which is present at both integration
points, is underlined. The boxed area represents the NASTI construct and the direction of neoR transcription is indicated. The vector DNA in both cases remains
intact except for the boxed sequence at the construct ends which have been deleted on insertion.
b
7101
151
201
251
1 II 1
351
41
451
511
551
601
651
711
751
801
851
901
°51
ICl01
22 Nucleic Acids Research, Vol. 19, No. I
1 2 34 5 6 78 9
1 6 8 c) 1 2 3 4 5 6 7 8 9
Figure 5. (a) A Northem blot of total RNA frm various ssues andhyrli to pobe 7A (see Fig.2). (1 =Brain; 2=Heart; 3=Kidney; 4=Liver; 5=lung; 6=muscle;
7=ovary; 8=testis; 9=thymus). The size of the 18S and 28S rRNAs are indicated. The lower panel shows the same blot hybridized to a GAPDH probe (53).
Note this probe detects high expression in muscle. (b) A Northern blot showing isues which hybridize to probe 8A (see Fig.2). Tissue types are numered as above.
(c)The same Northern blot as in Fig.5a hybridized to the cDNA clone p8E2. The size of the 18S and 28S rRNA bands are indicated. Tissue ypes are numbered as above.
possible that the insertion in 19/7 has trapped a promoter which
does not give rise to a stable transcript in ES cells or has activated
a promoter normally inactive.
We therefore detect transcription of DNA which flanks the
insert in both cell lines from what appear to be non-housekeeping
genes with high expression in adult testis.
The promoter within the 5' flanking DNA of cell line 19/8
has a bi-directional activity
The sequence of the cDNA clone, p8E2, which is contained in
19/8 is shown by underlining in Figure.4b. The end of the
sequence match to 19/8 corresponds with a consensus 5'splice
site (29), and the cDNA sequence continues for another 558 bp
beyond this. The cDNA also has a polyadenylation signal
AATAAAA and a poly-A tail 13 bp downstream of this. The
splice site and polyA tail indicate that the mRNA from which
the cDNA derives is transcribed in the opposite direction to the
neoR gene. All three reading frames are open in the cDNA, for
at least 647 bp. We do not know which is translated but none
show significant amino acid similarity to any sequence in the
databases. Between the cDNA and the NASTI insertion in 19/8
there are a series of potential transcription factor binding sites.
These include a TATA-like box in both orientations, and a
CCAAT box appropriately distanced from the TATA box to
regulate the p8E2 mRNA. There are five GC boxes, GGGCGG,
which are potential binding sites for the transcription factor Spl
(30), and could control expression in either or both directions.
DNA binding sites for Spl are known to be important in the
regulation of transcription in many genes, and are commonly
found within CpG islands (6). The binding of Spl may regulate
transcription in the presence or absence of either a TATA or
CAAT box and may direct transcription of the neoR$g in19/8. Other bi-directional promoters have been dcribed
(31,32,33,34), and may frequently occur in CpG islands (33).
We are at present analysing the bidiectional pr ter from 19/8
in more detail.
DISCUSSION
We present an analysis of several G418-resistant cell lines
produced from a single transfection experiment using a
promoterless neoR gene construct, NASTI. We have used the
method as a promoter trap to identify and mutate members of
a particular class of genes, those which are active in ES cells,
and to analyse the integration sites to determine the mechanisms
of non-homologous recombination.
The use ofpromoter and enhancer traps as a means of cloning
genes and regulatory regions has been used in rat cells (35), and
by microinjection of transgenes into mouse embryos (36,37).
DNA transfection and retroviral infection of EC and ES cells
has also been used for this purpose (38,39,40). Here we have
shown that in seven cell lines with single insertion sites, six have
occurred close to or within a CpG island. As our experiment
was designed to select for active proters, it was not unexected
that such regions would be targetted, as they contain promoters
for most genes (5,6). However the high fiequency of targetting
genes with CpG islands may indicate that there are a larger
number of such genes active in ES cells. Alternatively the
chromatin of CpG islands may be more susceptible to DNA
integration than non-island chromatin. We are currently
examining this latter hypothesis in more detail.
It has been previously suggested that expressed genes with an
opened chromatin conformation are likely targets for integration
(41), and it has been shown that CpG islands have such an altered
structure (7). DNA in these open regions may be transiently
exposed during normal cellular processes such as transcription
and replication and allow a high level of recombination with
exogenous DNA. Our data are consistent with this hypothesis
and could also account for the high frequency of homologous
recombinaion seen with some targetted genes such as HPRT(42),
and N-myc (25).
Two integration sites analysed have the same sequence,
5'-AACTC-3', in the genomic DNA. hterestingly this sequence
encompasses the trinucleotides CTC on one strand and GTT on
a)
28S -
18S -
b)
..
..
...
.w v ....'.
28S
18S8
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the other. Both of these have been found to be significantly
overrepresented in a compilation of non-homologous integration
sites of transfected linear DNAs and may represent sites for DNA
topoisomerase I (43). The compilation also shows a significant
occurrence of CTC at position -1 and GTT at position +5 of
the breakpoints, which is where they occur in cell lines 19/7 and
19/8.
There has been speculation that many non-homologous
recombinations take place at Topo I sites (see review 44).
Furthermore, the integration sites in 19/7 and 19/8 also show
a 4 bp match with the 5' end of the transfected DNA construct
and a 4 bp and 1 bp match respectively, with the 3' end. Such
short regions of identity, between 1 and 5 bp, have been found
at a variety of 'illegitimate' recombination junctions in
mammalian cells (45,46,47). We propose therefore that Topo
I may initiate recombination by causing a nick in one, or both
strands, and that short regions of homology near the breakpoint
are exposed to recombination with the transfected DNA. This
would account for the integration of the vector into the mouse
genome in 19/7 and 19/8, without the addition of extra nucleotides
at the junction, or rearrangements commonly found at other
integration sites (48).
The results also show that the DNA within 1 kb of the neoR
gene in 19/7 and 19/8 contains promoter elements which direct
neoR transcription, and these promoter elements are also
responsible for the transcription of endogenous genes, which have
been detected by Northern blot analysis. The promoter region
in 19/8 has been shown to have bi-directional activity because
it is able to transcribe neoR in one direction and the p8E2
transcript in the other. Several CpG islands show bidirectional
promoter activtiy (30,31,32,33). Recently Johnson and Friedman
(49), tested two specific CpG island promoters, human HPRT
and PGK, and found a limited bidirectional activity. We are
currently screening cDNA libraries to characterise the genes
transcribed at the insertion site of 19/7 and 19/8.
In summary, we have shown that electroporation allows
integration ofDNA in a manner which minimizes rearrangement
of both vector and genomic DNA. By using a promoterless
construct we select for integration close to active promoters. The
frequency of insertions close to CpG islands suggests that these
are not only indicative of the 5' end of genes, but also that these
regions may be more susceptible to DNA integration. We propose
that non-homologous integration ofDNA occurs by preferential
Topo I cleavage at open chromatin, such as at CpG islands,
followed by recombination through short regions of sequence
similarity.
This method produces cell lines which can be used to generate
chimaeras with mutated genomes, marked by the insert at CpG
islands. These may provide a link between a physical map of
the genome, and a mutational map.
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